Conditions: Cystic Fibrosis
Intervention Type: Drug
Intervention Name: VX-770 placebo
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Drug" intervention "VX-770 placebo" on "Cystic Fibrosis".
-
A Phase 1, Randomized, Double-Blind, Placebo Controlled, Multiple-Dose, Dose-Escalation, Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects
NCTID: NCT01216046
-
A Phase 2, Multicenter, Double-Blinded, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-809 Alone and in Combination With VX-770 in Subjects With Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation
NCTID: NCT01225211
-
A Phase 2, Multicenter, Double-Blinded, Placebo Controlled, 3-Part Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-661 Monotherapy and VX-661/VX-770 Cotherapy in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
NCTID: NCT01531673